The content on this site is intended for healthcare professionals only
Dr Bishal Gyawali speaks to ecancer about the workshop at Choosing Wisely 2022 Mumbai, which focused on clinical trials.
His talk explored the control arm treatments in clinical trials for low-middle-income countries.
He concludes by stating that LMIC should be selective in spending resources only on those trials that are meaningful to their patients.
The Vanessa Moss Prize: celebrating research into cancer health disparities
Prostate cancer
Tele-mentoring: Impact of project ECHO
Gastro-intestinal endoscopy capacity in Nigeria: strengths and challenges
Colorectal cancer risk factors in Nigeria
Introducing oncology to undergraduate medical and allied health sciences students
OncoAlert Round Up for September 15-21, 2023
iCCaRE Consortium for Black Men: Second Discussion
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
